NovogeneAIT Genomics, headquartered in Singapore, is a premier provider of multi-omics services and solutions. Established in 2016 through a strategic joint venture between Novogene and AITbiotech, we have grown to be one of the largest NGS service providers in Southeast Asia. Our unwavering commitment to delivering high-quality, efficient, and cost-effective omics solutions has propelled us to the forefront of genomic research. NovogeneAIT Genomics offers an extensive range of multi-omics services, including genomics, transcriptomics, single-cell/spatial transcriptomics, metagenomics, and proteomics. Operating from our cutting-edge sequencing center in Singapore, we are dedicated to advancing scientific research by providing superior data quality. For more information, visit www.novogene.com/amea-en/
Looking for a particular NovogeneAIT employee's phone or email?
The NovogeneAIT annual revenue was $379.5 million in 2026.
Justin Lee is the CEO of NovogeneAIT.
54 people are employed at NovogeneAIT.
The NAICS codes for NovogeneAIT are [453210, 4532, 453, 45321, 45].
The SIC codes for NovogeneAIT are [59, 594].